This is the authors' abstract. We don't add key points for this paper.
The term "transgender" encompasses diverse gender identities, including those where identity differs from the sex assigned at birth (trans men, trans women, non-binary individuals, gender-fluid persons, among others). Hormone therapy and gender affirmation surgeries are crucial to aligning the body with the desired gender identity, with trans men receiving testosterone therapy and trans women receiving estradiol, often accompanied by gender affirmation surgeries (GAS). Beyond medical and surgical care, mental health care is essential; hence, gender-affirming hormone therapy (GAHT) must be monitored by a multidisciplinary team (including endocrinologists, gynecologists, psychologists, psychiatrists, among others). Transgender individuals face significant barriers to accessing healthcare services, including long waiting times in public health systems, high costs in private clinics, and legal challenges for document changes. Discrimination and prejudice also pose obstacles, particularly for trans women, who encounter specific challenges such as limited access to HIV/AIDS treatment. Additionally, societal taboos and lack of awareness contribute to treatment abandonment and the pursuit of cheaper and less safe clandestine treatments. This article reviews the necessary measures for gender transition, emphasizing the importance of specialized medical and psychosocial support. Properly administered hormone therapy can significantly improve the quality of life for trans women and travestis, facilitating greater harmony with their gender identity.
No takes yet. Share an insight, caveat, or question.
Aguiar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: